Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and Edema, Pulmonary

sb 203580 has been researched along with Edema, Pulmonary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dierkes, C; Eisenhardt, N; Ermert, L; Ermert, M; Kuttner, D; Seeger, W1
Belvisi, MG; Birrell, M; Foster, M; Hele, D; McCluskie, K; Webber, S1

Other Studies

2 other study(ies) available for sb 203580 and Edema, Pulmonary

ArticleYear
Cyclooxygenase-2-dependent and thromboxane-dependent vascular and bronchial responses are regulated via p38 mitogen-activated protein kinase in control and endotoxin-primed rat lungs.
    Laboratory investigation; a journal of technical methods and pathology, 2003, Volume: 83, Issue:3

    Topics: Animals; Bacterial Toxins; Bronchoconstriction; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endotoxins; Enzyme Inhibitors; Imidazoles; Immunohistochemistry; In Vitro Techniques; Isoenzymes; Lipopolysaccharides; Lung; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Oxazoles; p38 Mitogen-Activated Protein Kinases; Perfusion; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Pulmonary Edema; Pyridines; Rats; Rats, Sprague-Dawley; Thromboxanes; Vasoconstriction

2003
Effect of the p38 kinase inhibitor, SB 203580, on sephadex induced airway inflammation in the rat.
    The European respiratory journal, 2000, Volume: 16, Issue:5

    Topics: Animals; Dextrans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; Indicators and Reagents; Lung; Male; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pneumonia; Pulmonary Edema; Pyridines; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2000